VTGN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Vistagen Therapeutics Inc (VTGN).


$142.69M Market Cap.

As of 06/11/2024 5:00 PM ET (MRY) • Disclaimer

VTGN Market Cap. (MRY)


VTGN Shares Outstanding (MRY)


VTGN Assets (MRY)


Total Assets

$123.65M

Total Liabilities

$9.37M

Total Investments

$0

VTGN Income (MRY)


Revenue

$1.06M

Net Income

-$29.36M

Operating Expense

$34.09M

VTGN Cash Flow (MRY)


CF Operations

-$25.81M

CF Investing

-$61.00K

CF Financing

$128.40M

VTGN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

VTGN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$123,653,000 (486.33%)

$21,089,200 (-71.75%)

$74,643,400 (-31.07%)

$108,281,300 (1775.88%)

Assets Current

$120,672,000 (589.26%)

$17,507,400 (-75.34%)

$70,998,000 (-31.81%)

$104,117,500 (6488.88%)

Assets Non-Current

$2,981,000 (-16.77%)

$3,581,800 (-1.74%)

$3,645,400 (-12.45%)

$4,163,800 (-0.68%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$114,286,000 (846.08%)

$12,080,000 (-81.33%)

$64,715,300 (-29.64%)

$91,978,500 (1705.38%)

Property Plant & Equipment Net

$2,255,000 (-18.52%)

$2,767,600 (-10.03%)

$3,076,300 (-14.24%)

$3,587,000 (-5.34%)

Cash & Equivalents

$119,166,000 (616.25%)

$16,637,600 (-75.58%)

$68,135,300 (-33.92%)

$103,108,300 (7508.91%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$3,465,000 (14.40%)

$3,028,900 (8.11%)

$2,801,600 (-28.36%)

$3,910,500 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,547,000 (-37.45%)

$2,473,100 (-10.35%)

$2,758,600 (229.07%)

$838,300 (-54.36%)

Accumulated Retained Earnings (Deficit)

-$356,214,000 (-8.98%)

-$326,851,700 (-22.14%)

-$267,604,000 (-21.73%)

-$219,841,600 (-8.88%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,120,000 (-22.05%)

$2,719,800 (-10.49%)

$3,038,700 (-18.28%)

$3,718,600 (-9.12%)

Debt Current

$550,000 (-7.19%)

$592,600 (36.76%)

$433,300 (17.81%)

$367,800 (-1.45%)

Debt Non-Current

$1,570,000 (-26.19%)

$2,127,200 (-18.35%)

$2,605,400 (-22.25%)

$3,350,800 (-9.89%)

Total Liabilities

$9,367,000 (3.97%)

$9,009,200 (-9.26%)

$9,928,100 (-39.10%)

$16,302,800 (41.74%)

Liabilities Current

$5,123,000 (12.16%)

$4,567,400 (-20.78%)

$5,765,100 (37.62%)

$4,189,000 (51.16%)

Liabilities Non-Current

$4,244,000 (-4.45%)

$4,441,800 (6.70%)

$4,163,000 (-65.63%)

$12,113,800 (38.75%)

VTGN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,064,000 (568.10%)

-$227,300 (-120.50%)

$1,108,900 (1.78%)

$1,089,500 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,063,000 (-4.10%)

$14,663,600 (8.78%)

$13,480,000 (89.92%)

$7,097,600 (-4.44%)

Research & Development Expense

$20,022,000 (-54.88%)

$44,377,100 (25.33%)

$35,407,800 (196.90%)

$11,925,700 (-10.83%)

Operating Expenses

$34,085,000 (-42.27%)

$59,040,700 (20.77%)

$48,887,800 (156.99%)

$19,023,300 (-8.55%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$4,000 (-32.20%)

$5,900 (73.53%)

$3,400 (30.77%)

$2,600 (0.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$29,362,000 (50.44%)

-$59,247,700 (-24.05%)

-$47,762,400 (-166.32%)

-$17,934,200 (13.67%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$29,362,000 (50.44%)

-$59,247,700 (-24.05%)

-$47,762,400 (-166.32%)

-$17,934,200 (13.67%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$945,100 (-96.12%)

$24,385,600 (1829.85%)

Net Income Common Stock

-$29,362,000 (50.44%)

-$59,247,700 (-21.64%)

-$48,707,500 (-15.09%)

-$42,319,800 (-92.03%)

Weighted Average Shares

$19,354,500 (178.13%)

$6,958,749 (5.45%)

$6,599,287 (129.85%)

$2,871,093 (79.58%)

Weighted Average Shares Diluted

$19,354,500 (178.13%)

$6,958,749 (5.45%)

$6,599,287 (129.85%)

$2,871,093

Earning Before Interest & Taxes (EBIT)

-$29,358,000 (50.44%)

-$59,241,800 (-24.04%)

-$47,759,000 (-166.34%)

-$17,931,600 (13.67%)

Gross Profit

$1,064,000 (568.10%)

-$227,300 (-120.50%)

$1,108,900 (1.78%)

$1,089,500 (0%)

Operating Income

-$33,021,000 (44.29%)

-$59,268,000 (-24.05%)

-$47,778,900 (-166.42%)

-$17,933,800 (13.79%)

VTGN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$61,000 (91.76%)

-$740,300 (-269.41%)

-$200,400 (27.23%)

-$275,400 (0%)

Net Cash Flow from Financing

$128,402,000 (12419.10%)

-$1,042,300 (-109.94%)

$10,483,900 (-90.81%)

$114,102,100 (2744.16%)

Net Cash Flow from Operations

-$25,813,000 (48.08%)

-$49,715,100 (-9.85%)

-$45,256,500 (-274.84%)

-$12,073,500 (23.38%)

Net Cash Flow / Change in Cash & Cash Equivalents

$102,528,000 (299.09%)

-$51,497,700 (-47.25%)

-$34,973,000 (-134.37%)

$101,753,200 (966.34%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$528,300 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$61,000 (71.23%)

-$212,000 (-5.79%)

-$200,400 (27.23%)

-$275,400 (0%)

Issuance (Repayment) of Debt Securities

-$985,000 (4.91%)

-$1,035,900 (-34430.00%)

-$3,000 (99.21%)

-$382,000 (-28.79%)

Issuance (Purchase) of Equity Shares

$129,387,000 (2021771.88%)

-$6,400 (-100.06%)

$10,486,900 (-90.84%)

$114,484,100 (2557.23%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,182,000 (-34.60%)

$3,336,400 (-4.15%)

$3,480,700 (50.93%)

$2,306,100 (-39.64%)

Depreciation Amortization & Accretion

$568,000 (6.93%)

$531,200 (-25.30%)

$711,100 (48.89%)

$477,600 (363.24%)

VTGN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-2759.60% (-110.59%)

26065.90% (693.43%)

-4392.40% (-13.08%)

-3884.30%

EBITDA Margin

-2705.80% (-110.48%)

25829.60% (708.79%)

-4242.80% (-164.84%)

-1602.00%

Return on Average Equity (ROAE)

-41.90% (80.83%)

-218.60% (-248.64%)

-62.70% (31.70%)

-91.80% (-114.40%)

Return on Average Assets (ROAA)

-37.60% (76.17%)

-157.80% (-199.43%)

-52.70% (24.06%)

-69.40% (74.19%)

Return on Sales (ROS)

-2759.20% (-110.59%)

26063.30% (705.15%)

-4306.90% (-161.67%)

-1645.90%

Return on Invested Capital (ROIC)

-918.50% (57.89%)

-2181.20% (-52.29%)

-1432.30% (-357.60%)

-313.00% (17.28%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.47 (-689.55%)

-0.44 (91.27%)

-5.04 (-15.97%)

-4.35 (-393.98%)

Price to Sales Ratio (P/S)

96.05 (183.86%)

-114.53 (-151.73%)

221.39 (31.47%)

168.39

Price to Book Ratio (P/B)

1.25 (-44.83%)

2.26 (-42.78%)

3.96 (20.60%)

3.28 (189.08%)

Debt to Equity Ratio (D/E)

0.08 (-89.01%)

0.75 (387.58%)

0.15 (-13.56%)

0.18 (108.82%)

Earnings Per Share (EPS)

-1.52 (82.14%)

-8.51 (-15.31%)

-7.38 (49.80%)

-14.7 (2.00%)

Sales Per Share (SPS)

0.06 (266.67%)

-0.03 (-119.64%)

0.17 (-55.67%)

0.38 (0%)

Free Cash Flow Per Share (FCFPS)

-1.34 (81.37%)

-7.17 (-4.17%)

-6.89 (-60.15%)

-4.3 (56.36%)

Book Value Per Share (BVPS)

5.91 (240.15%)

1.74 (-82.30%)

9.81 (-69.39%)

32.04 (993.86%)

Tangible Assets Book Value Per Share (TABVPS)

6.39 (110.79%)

3.03 (-73.20%)

11.31 (-70.01%)

37.71 (944.42%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-4 (63.64%)

-11 (-1000.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.64 (-587.10%)

-0.09 (97.51%)

-3.73 (67.66%)

-11.54 (-884.47%)

Asset Turnover

0.01 (333.33%)

-0.01 (-150.00%)

0.01 (-33.33%)

0.02 (0%)

Current Ratio

23.55 (514.53%)

3.83 (-68.88%)

12.31 (-50.45%)

24.86 (4260.53%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$25,874,000 (48.18%)

-$49,927,100 (-9.83%)

-$45,456,900 (-268.10%)

-$12,348,900 (21.63%)

Enterprise Value (EV)

$18,388,604 (236.88%)

$5,458,518 (-96.89%)

$175,536,064 (-12.83%)

$201,378,700 (731.53%)

Earnings Before Tax (EBT)

-$29,358,000 (50.44%)

-$59,241,800 (-24.04%)

-$47,759,000 (-166.34%)

-$17,931,600 (13.67%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$28,790,000 (50.96%)

-$58,710,600 (-24.79%)

-$47,047,900 (-169.55%)

-$17,454,000 (15.55%)

Invested Capital

$1,484,000 (-43.01%)

$2,604,000 (-31.14%)

$3,781,700 (-19.58%)

$4,702,600 (-18.04%)

Working Capital

$115,549,000 (792.96%)

$12,940,000 (-80.16%)

$65,232,900 (-34.72%)

$99,928,500 (8489.60%)

Tangible Asset Value

$123,653,000 (486.33%)

$21,089,200 (-71.75%)

$74,643,400 (-31.07%)

$108,281,300 (1775.88%)

Market Capitalization

$142,693,104 (421.73%)

$27,350,018 (-89.32%)

$256,094,664 (-15.15%)

$301,809,100 (1330.12%)

Average Equity

$70,016,250 (158.34%)

$27,102,875 (-65.14%)

$77,742,400 (68.64%)

$46,100,025 (1433.47%)

Average Assets

$77,987,275 (107.65%)

$37,556,325 (-59.35%)

$92,396,600 (51.48%)

$60,997,500 (644.19%)

Invested Capital Average

$3,196,300 (17.68%)

$2,716,075 (-18.54%)

$3,334,400 (-41.81%)

$5,729,850 (4.37%)

Shares

27,025,209 (269.66%)

7,310,811 (6.20%)

6,884,196 (45.76%)

4,723,100 (195.42%)